share_log

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38

HC Wainwright & Co.重申买入格林威治生命科学,将目标价下调至38美元
Benzinga ·  2023/04/10 12:10

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price target from $78 to $38.

HC Wainwright & Co. 分析师陈毅重申格林威治生命科学(纳斯达克股票代码:GLSI)的买入,并将目标股价从78美元下调至38美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发